Market Tracker

06/27 3:30am ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.39
Delayed Data
As of Jun 24
 -0.0148 / -3.66%
Today’s Change
0.29
Today|||52-Week Range
1.40
-66.67%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.40
Today’s open0.38
Day’s range0.38 - 0.40
Volume19,165,412
Average volume (3 months)1,923,541
Market cap$91.2M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...+0.06+0.96%
OCXOncoCyte Corp-0.16-4.30%
CORICorium International...+0.06+1.50%
NAVBNavidea Biopharmaceu...-0.07-10.25%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateJuly 11, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts